AMGEN INC (AMGN) revenue & profit

AMGEN INC (AMGN): revenue $36.8B, net income $7.7B in 2025; latest quarter +9.5% year over year. From SEC filings.

$36.8BRevenue 2025

TickerAMGN (Nasdaq)

IndustryHealthcare · Biological Products, (No Diagnostic Substances)

Revenue 2025$36.8B

Net income 2025$7.7B

Net margin21%

Annual revenue growth+10%

Latest quarter (2026 Q2) · Revenue$10.1B

vs. same quarter last year+9.5%

Latest quarter · Net income$2.4B

Annual revenue & net income

Year	Revenue	Net income
2022	$26.3B	$6.6B
2023	$28.2B	$6.7B
2024	$33.4B	$4.1B
2025	$36.8B	$7.7B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · The original uploader was King of Hearts at English Wikipedia. · Public domain · Wikimedia Commons

📷 Coolcaesar · CC BY-SA 3.0 · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.